NDC 23731-6030-02 - triCitrasol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23731-6030
- Requested NDC
- 23731-6030-02
- Package NDCs from labels
- 23731-6030-3, 23731-6030-1, 23731-6030-2, 23731-6030-02
- Manufacturer
- Citra Labs LLC | Citra Labs, LLC
- Effective date
- 2023-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| triCitrasol - Citra Labs LLC | Citra Labs, LLC | Citra Labs LLC | Citra Labs, LLC | 2023-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 23731-6030-1 | 2023-02-14 | triCitrasol ® |
| 23731-6030-2 | 2023-02-14 | triCitrasol ® |
| 23731-6030-1 | 2023-01-30 | triCitrasol ® |
| 23731-6030-2 | 2023-01-30 | triCitrasol ® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23731-6030-1 | triCitrasol | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 23731-6030-2 | triCitrasol | 25 in 1 CASE | SOLUTION | 25 | 5 | |
| 23731-6030-3 | triCitrasol | 30 mL in 1 VIAL, SINGLE-USE | SOLUTION | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23731-6030 | TRICITRASOL (TRISODIUM CITRATE DIHYDRATE) SOLUTION [CITRA LABS LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20230215_64e7652c-1437-43bd-8ea2-3cafab447b8c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23731-6030-3 | ML - Milliliter | 23731-6030 | 3142e42d-871a-4bc9-931d-90270bc1e872 | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Trisodium Citrate dihydrate | ACTIVE INGREDIENT | B22547B95K | TRICITRASOL (TRISODIUM CITRATE DIHYDRATE) SOLUTION [CITRA LABS LLC] | 2 | |
| Anhydrous Citric Acid | ACTIVE MOIETY | XF417D3PSL | TRICITRASOL (TRISODIUM CITRATE DIHYDRATE) SOLUTION [CITRA LABS LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Nausea Relief | SODIUM CITRATE DIHYDRATE | CVS PHARMACY,INC. | a5f9de6f-70d8-4bb0-8a5b-3dd120df2990 | 2026-08-14 | Warnings | B22547B95K |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | B22547B95K |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | B22547B95K |
| Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE | LABORATORIOS GRIFOLS SA | db8334be-5b8b-4811-811a-efbe32b6d147 | 2026-04-14 | Warnings | B22547B95K |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | B22547B95K |
| WALGREENS UPSET STOMACH and NAUSEA RELIEF | SODIUM CITRATE DIHYDRATE | WALGREENS CO. | 2de7ff66-af75-4d9d-b493-29b37dadc5d8 | 2026-01-15 | Warnings | B22547B95K |
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2025-10-01 | Warnings | B22547B95K |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | B22547B95K |
| Nauzene Chewables Ginger Honey | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | 25c9825d-a4e8-4671-e063-6294a90ab46d | 2025-06-24 | Warnings | B22547B95K |
| Nauzene | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | a60660b2-c5db-45a0-885f-de93e655380d | 2025-04-29 | Warnings | B22547B95K |
| Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | c9d0e9c8-379f-4895-b272-329efab575c4 | 2025-01-24 | Warnings, Adverse reactions | B22547B95K |
| Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 0775912f-f14a-4967-ac00-c8c1b36040bf | 2025-01-23 | Warnings, Adverse reactions | B22547B95K |
| Emetrol Powder Non-Drowsy | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9d8d2ee7-9db7-4be7-8c73-511eb2e32459 | 2025-01-08 | Warnings | B22547B95K |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | B22547B95K |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | B22547B95K |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | B22547B95K |
| ANTICOAGULANT SODIUM CITRATE | TRISODIUM CITRATE DIHYDRATE | Baxter Healthcare Corporation | 7025a0f9-1a56-4416-a3a4-925d755aed90 | 2024-04-02 | B22547B95K | |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | B22547B95K |
| Emetrol Chewables Mixed Berry | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 4965fab0-828d-4f1d-8d43-a636e0a8c1ea | 2023-03-23 | Warnings | B22547B95K |
| Emetrol Chewables Orange | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | e9072f9d-d74c-4e43-bcfe-ee005577df35 | 2023-03-23 | Warnings | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.